1-(bromomethyl)-2-methoxynaphthalene | 91571-00-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-(bromomethyl)-2-methoxynaphthalene
• 英文别名: 1-Brommethyl-2-methoxy-naphthalin；1-(1-Bromomethyl)-2-methoxynaphthalene
• CAS: 91571-00-5
• 化学式: C₁₂H₁₁BrO
• 分子量: 251.123
• InChiKey: FITUXDWDCPOBIX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(bromomethyl)-2-methoxynaphthalene 在 三乙酰氧基硼氢化钠 、 caesium carbonate 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 、 溶剂黄146 、 N,N-二甲基甲酰胺 为溶剂， 反应 48.0h， 生成 3-[(2-Methoxynaphthalen-1-yl)methyl]-7-[(1,3,5-trimethylpyrazol-4-yl)methylamino]-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-one
  参考文献：
  名称：

  Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket

  摘要：

  Sirtuins (SIRTs) are NAD-dependent deacylases, known to be involved in a variety of pathophysiological processes and thus remain promising therapeutic targets for further validation. Previously, we reported a novel thienopyrimidinone SIRT2 inhibitor with good potency and excellent selectivity for SIRT2. Herein, we report an extensive SAR study of this chemical series and identify the key pharmacophoric elements and physiochemical properties that underpin the excellent activity observed. New analogues have been identified with submicromolar SIRT2 inhibtory activity and good to excellent SIRT2 subtype-selectivity. Importantly, we report a cocrystal structure of one of our compounds (29c) bound to SIRT2. This reveals our series to induce the formation of a previously reported selectivity pocket but to bind in an inverted fashion to what might be intuitively expected. We believe these findings will contribute significantly to an understanding of the mechanism of action of SIRT2 inhibitors and to the identification of refined, second generation inhibitors.

  DOI：

  10.1021/acs.jmedchem.6b01690
• 作为产物：
  描述：

  2-甲氧基-1-萘醛 在 sodium tetrahydroborate 、 三溴化磷 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 生成 1-(bromomethyl)-2-methoxynaphthalene
  参考文献：
  名称：

  [EN] ION CHANNEL ANTAGONISTS/BLOCKERS AND USES THEREOF
  [FR] ANTAGONISTES/BLOQUEURS DES CANAUX IONIQUES ET LEURS UTILISATIONS

  摘要：

  提供了离子通道拮抗剂/阻断剂及其用途。具体而言，提供了式（I）的化合物或药用盐、立体异构体、溶剂合物或前药，其制备方法及应用。每个式中的各个基团的定义可在说明书中找到详细信息。还提供了用于治疗心脏病和其他离子通道相关疾病的药物组合物。

  公开号：

  WO2021114313A1

文献信息

• [EN] TETRAHYDRO-BENZODIAZEPINONES<br/>[FR] TÉTRAHYDRO-BENZODIAZÉPINONES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2015071393A1

  公开（公告）日：2015-05-21

  Disclosed are compounds of Formula I, or pharmaceutically acceptable salts thereof, wherein W, X, Y, Z, R1, R2, R3, R4 and R5 are as described in this application, and methods of using said compounds in the treatment of cancer.

  本申请公开了具有I式化合物或其药用可接受盐的化合物，其中W、X、Y、Z、R1、R2、R3、R4和R5如本申请所述，并且使用所述化合物治疗癌症的方法。
• [EN] DIMERIC COMPOUNDS<br/>[FR] COMPOSÉS DIMÈRES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2014090709A1

  公开（公告）日：2014-06-19

  Disclosed are compounds of Formula (I), or pharmaceutically acceptable salts thereof, wherein Z, X, Q and R1 are as described in this application, and methods of using the compounds in the treatment of cancer.

  揭示了式（I）的化合物或其药学上可接受的盐，其中Z、X、Q和R1如本申请中所述，并且使用这些化合物治疗癌症的方法。
• [EN] ION CHANNEL ANTAGONISTS/BLOCKERS AND USES THEREOF<br/>[FR] ANTAGONISTES/BLOQUEURS DES CANAUX IONIQUES ET LEURS UTILISATIONS
  申请人：SHANGHAI EAST HOSPITAL

  公开号：WO2021114313A1

  公开（公告）日：2021-06-17

  Provided are ion channel antagonists/blockers and uses thereof. Specifically, it provides the compounds of formula (I) or pharmaceutically acceptable salts, stereoisomers, solvates or prodrugs, preparation method therefor and application thereof. Definition of each group in the formula can be found in the specification for details. Provided is also pharmaceutical composition useful for treatment of heart disease and other ion channel related diseases.

  提供了离子通道拮抗剂/阻断剂及其用途。具体而言，提供了式（I）的化合物或药用盐、立体异构体、溶剂合物或前药，其制备方法及应用。每个式中的各个基团的定义可在说明书中找到详细信息。还提供了用于治疗心脏病和其他离子通道相关疾病的药物组合物。
• Access to Diarylmethanols by Wittig Rearrangement of <i>ortho-</i>, <i>meta-</i>, and <i>para-</i>Benzyloxy-<i>N</i>-Butylbenzamides
  作者：R. Alan Aitken、Andrew D. Harper、Ryan A. Inwood、Alexandra M. Z. Slawin

  DOI：10.1021/acs.joc.1c03160

  日期：2022.4.1

  promoter of the [1,2]-Wittig rearrangement of aryl benzyl ethers and thus allow the two-step synthesis of isomerically pure substituted diarylmethanols starting from simple hydroxybenzoic acid derivatives. The method is compatible with a wide range of functional groups including methyl, methoxy, and fluoro, although not with nitro and, unexpectedly, is applicable to meta as well as ortho and para isomeric

  已发现N-丁基酰胺基团 CONHBu 是芳基苄基醚的 [1,2]-Wittig 重排的有效促进剂，因此允许从简单的羟基苯甲酸衍生物开始两步合成异构纯的取代的二芳基甲醇. 该方法与包括甲基、甲氧基和氟在内的多种官能团兼容，但不适用于硝基，而且出乎意料的是，该方法适用于间位以及邻位和对位异构体系列。
• Base-Induced Cyclisation of ortho-Substituted 2-Phenyloxazolines to Give 3-Aminobenzofurans and Related Heterocycles
  作者：R. Aitken、Andrew Harper、Alexandra Slawin

  DOI：10.1055/s-0036-1588503

  日期：2017.9

  butyllithium and potassium tert-butoxide results in cyclisation with ring opening of the oxazoline to give 2-aryl-3-aminobenzofurans. The reaction also occurs with the corresponding benzylthio and benzylamino compounds to give benzothiophenes and indoles, respectively. Use of an ortho-allyloxyphenyloxazoline gives the corresponding 2-vinylbenzofuran, while both α-methylbenzyloxy and benzylsulfonyl compounds

  用丁基锂和叔丁醇钾处理邻苄氧基苯基恶唑啉导致环化反应，恶唑啉开环得到 2-芳基-3-氨基苯并呋喃。该反应还与相应的苄硫基和苄基氨基化合物发生反应，分别生成苯并噻吩和吲哚。使用邻-烯丙氧基苯基恶唑啉产生相应的 2-乙烯基苯并呋喃，而 α-甲基苄氧基和苄基磺酰基化合物均形成稳定的螺恶唑烷产物。已确定氨基苯并噻吩产物的 X 射线结构。